House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Infectious diseases

Human and animal bites: antimicrobial prescribing

NICE · 2020 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

NICE bite guidance separates prophylaxis from treatment of infection and distinguishes human, cat and other-pet bites by skin penetration, bleeding, wound features and patient risk. Wound care and assessment of rabies, tetanus and bloodborne infections remain separate essentials. This summary includes key escalation criteria and the standard adult first-line antibiotic option.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Assess the wound and wider exposure risk

  • Record the biting species, site, depth and severity of injury, and signs of infection. Irrigate the wound and debride where needed as part of initial management. [1]
  • Assess tetanus, rabies and bloodborne-virus risk and take appropriate action. Consider safeguarding concerns in children and vulnerable adults rather than viewing the injury solely as an antibiotic decision. [1]
  • Seek microbiology advice for wild or exotic animal bites because organisms and nonbacterial risks may differ. Consider such advice for domestic or farm animal bites unfamiliar to the treating clinician. [1]

Distinguish skin penetration and bleeding

  • Do not offer prophylactic antibiotics for a human bite that has left the skin intact. Offer prophylaxis when the skin is broken and blood has been drawn. [1]
  • For a human bite that breaks skin without bleeding, consider prophylaxis if a high-risk site is involved or comorbidity increases the risk of serious infection. Listed sites include hands, feet, face, genitals, cartilage and poorly perfused skin. [1]
  • For cat bites, give no prophylaxis if skin is intact, offer it when the wound breaks skin and bleeds, and consider it for a nonbleeding skin break if the wound could be deep. [1]

Use additional wound features to select prophylaxis

  • For dog or other traditional-pet bites apart from cats, do not offer prophylaxis when skin is intact or when it is broken without bleeding. [1]
  • For a bleeding dog or other traditional-pet bite (excluding cats), offer prophylaxis if it penetrates bone, joint, tendon or vascular structures, is deep or a puncture or crush injury, causes major tissue damage, or is visibly contaminated. [1]
  • For a bleeding dog or other traditional-pet bite (excluding cats) involving a high-risk site or a patient with serious-infection risk from comorbidity, consider prophylaxis. Examples of relevant comorbidity include diabetes, immunosuppression, asplenia and decompensated liver disease. [1]

Treat infection and provide explicit safety-netting

  • If the wound has discharge, whether purulent or not, take a swab to guide treatment. Offer antibiotics when pain, inflammation, fever, discharge or unpleasant smell suggests infection. [1]
  • Explain antibiotic adverse effects and advise review if infection develops, worsens rapidly or substantially, or fails to start improving within 24–48 hours of treatment. [1]
  • Reassess if the patient becomes systemically unwell or pain is severe and disproportionate, as well as for worsening infection or absent early improvement. In people with communication difficulties, behavioural change may indicate pain. [1]
  • Review antibiotic choice when microbiology results return. If a change is needed, use a narrower-spectrum option where possible. [1]

Escalate deep injury and serious illness

  • Refer to hospital for suspected severe cellulitis, abscess, bone or joint infection, necrotising fasciitis or sepsis, or a penetrating injury involving major deep structures such as vessels, nerves, muscles, tendons, bone or the central nervous system. [1]
  • Consider referral or specialist advice for systemic illness, lymphangitis, infection after prophylaxis or important pre-existing infection risk. Infection unresponsive to oral treatment or in poorly perfused tissue is also a reason to consider escalation. [1]

Choose route, age-appropriate treatment and duration

  • Use an oral antibiotic when the patient can take it and illness severity does not require intravenous treatment. If intravenous treatment is started, review within 48 hours and switch to oral treatment when possible. [1]
  • For adults aged 18 years and over, the first oral choice is co-amoxiclav at 250/125 mg or 500/125 mg three times daily. The table differentiates a 3-day prophylaxis course from a 5-day treatment course. [1]
  • In pregnancy, seek specialist advice if penicillin allergy or another reason makes co-amoxiclav unsuitable. For other special populations, consult drug-specific guidance rather than applying the standard table without adjustment. [1]
  • For children below 1 month, obtain specialist advice. Older children require the age- and weight-specific table rather than extrapolation from adult doses. [1]
  • Most infected bites can be treated for 5 days. After clinical review, extend to 7 days when warranted by substantial tissue destruction or penetration of bone, joint, tendon or vascular structures. [1]

Limitations and use

  • Detailed paediatric dosing, alternative allergy regimens and intravenous doses remain in the original tables and drug references. The summary does not substitute for those population-specific prescriptions.
  • Rabies, tetanus and bloodborne-virus post-exposure protocols are not provided by this antimicrobial guideline.
  • The standard course and dose statements require adjustment for the specific patient, including renal or hepatic impairment and pregnancy where relevant.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Human and animal bites: antimicrobial prescribing

    Selected recommendation material consulted

Original guideline

Publication details

Issuing organisation
NICE
First published
4 November 2020
Resource type
Clinical guideline · House clinical summary

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Assess the wound and wider exposure risk
  • Distinguish skin penetration and bleeding
  • Use additional wound features to select prophylaxis
  • Treat infection and provide explicit safety-netting
  • Escalate deep injury and serious illness
  • Choose route, age-appropriate treatment and duration
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House